Will Myriad ruling stifle innovation? Many still see plenty of incentives for genetics companies

Med City News: Craig A. Nard, the Tom J.E. and Bette Lou Walker Professor of Law, discussed the Supreme Court’s ruling on Myriad Genetics and how it may spell bad news for the future innovation. “The cDNA (protected under the ruling) contains all the coding portions of the DNA sequence—that’s really important from the business perspective,” Nard said.